New York AG Sues Insys Alleging Illegal Off-Label Promotion, Bribery to Boost Fentanyl Drug

Drug Industry Daily
A A
New York’s attorney general is suing Insys for deceptive marketing of the spray form of one of its fentanyl products, a move the state says is part of a multi-pronged strategy to address the addiction crisis.

To View This Article:

Login

Subscribe To Drug Industry Daily